Joshua R. Disbrow, Chief Executive Officer at AYTU BIOPHARMA, INC (AYTU), bought 222,000 shares at $0.24 ($53K) on 2022-11-18, disclosed to the SEC on 2022-11-28.
Seasonal purchase ($53k) by Chief Executive Officer — this insider has traded AYTU in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ZYXI | BUY | 2024-07-30 | $58K | — | Filing → |
| AYTU | BUY | 2023-06-15 | $26K | — | Filing → |
| AYTU | BUY | 2022-12-21 | $25K | — | Filing → |